Macrobid vs. Clindamycin
See how Macrobid and Clindamycin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Macrobid is a narrow-spectrum antibiotic reserved for uncomplicated bladder infections, while clindamycin treats serious infections across the skin, lungs, bones, and abdomen.
Clindamycin carries a boxed warning for C. difficile-associated diarrhea and colitis, a risk not associated with Macrobid.
Macrobid must be avoided in significant kidney impairment, while clindamycin's dose and schedule vary widely depending on infection severity and route.
Macrobid vs. Clindamycin Drug Summary
Macrobid
Macrobid is a urinary anti-infective in the nitrofuran class, used to treat uncomplicated urinary tract infections caused by susceptible bacteria like E. coli. It's taken as an oral capsule twice a day for seven days and works by concentrating in urine rather than the bloodstream.
Clindamycin
Clindamycin is a lincosamide antibiotic used for serious infections caused by anaerobic bacteria, streptococci, staphylococci, and other susceptible organisms, including skin, respiratory, and abdominal infections. It comes in oral, IV, and topical forms, with oral capsules typically taken every six hours.
Macrobid vs. Clindamycin Side Effects
Macrobid
Clindamycin
Macrobid vs. Clindamycin Dosage
Macrobid
Clindamycin
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg every 6 hours | At the start |
| Maximum dose | up to 4800 mg/day IV | If needed |
| Dose changes | 6 increases | As tolerated |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Clindamycin
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg every 6 hours | At the start |
| Maximum dose | up to 4800 mg/day IV | If needed |
| Dose changes | 6 increases | As tolerated |
Macrobid vs. Clindamycin Indications
Macrobid
Macrobid is FDA-approved specifically for acute, uncomplicated bladder infections (cystitis) caused by susceptible bacteria such as E. coli or S. saprophyticus. It is not approved for kidney infections or infections that have spread beyond the bladder. Doctors sometimes prescribe it off-label at low doses for long-term prevention of recurrent UTIs.
Acute uncomplicated UTI (cystitis)
Caused by susceptible E. coli or S. saprophyticus
Off-label: long-term UTI prevention
Not approved for kidney infections (pyelonephritis)
Clindamycin
Clindamycin treats serious infections from anaerobic bacteria as well as susceptible strep, staph, and pneumococcal organisms, including skin, respiratory, bone, joint, and abdominal infections. Topical and vaginal forms are also approved for acne and bacterial vaginosis. It's generally reserved for infections where less toxic antibiotics aren't appropriate, due to its C. diff risk.
Serious anaerobic bacterial infections
Skin, respiratory, bone, and joint infections
Acne (topical) and bacterial vaginosis (vaginal)
Off-label: penicillin-allergy surgical prophylaxis
Macrobid vs. Clindamycin Pros and Cons
Macrobid
Macrobid offers a targeted, short-course option for simple UTIs with minimal systemic exposure, but it isn't built for infections beyond the bladder. Coverage is usually straightforward for a short prescription, though it's unsuitable for patients with reduced kidney function.
Pros
Lower risk of C. diff-associated colitis than broad-spectrum antibiotics
Simple twice-daily, 7-day course for most UTIs
Long track record of reliable effectiveness against E. coli
Minimal systemic absorption limits some systemic side effects
Cons
Not usable in significant kidney impairment (CrCl under 60)
Risk of rare but serious lung and liver reactions with prolonged use
Not effective for infections outside the urinary tract
Contraindicated near labor and delivery at term
Clindamycin
Clindamycin covers a much wider range of serious bacterial infections and comes in multiple formulations, but that breadth comes with real risks like C. diff colitis. It's typically reserved for cases where narrower antibiotics won't work.
Pros
Works against a much broader range of bacteria and body sites
Available in oral, IV, topical, and vaginal forms for flexible use
Useful alternative for patients with a penicillin allergy
Can treat infections that have spread beyond one body system
Cons
Carries a boxed warning for C. diff-associated diarrhea and colitis
Oral capsules must be taken with plenty of fluid to avoid esophageal irritation
Not effective for meningitis due to poor CNS penetration
More frequent dosing schedule, every 6 to 8 hours, for oral and IV forms
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.